A phase II clinical trial of carbon-ion radiotherapy and concurrent S-1 chemotherapy for locally advanced pancreatic cancer (HIMAT1326)
Phase 2
Recruiting
- Conditions
- locally advanced pancreatic cancer
- Registration Number
- JPRN-UMIN000013803
- Lead Sponsor
- Ion Beam Therapy Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1) Invasion to mucosal membrane of stomach or intestine 2) Ascites on CT scan 3) Metallic stent at the bile duct 4) Use of flu cytosine, phenytoin, or warfarin potassium 5) Uncontrolled severe infection 6) Uncontrolled severe complication 7) Active double cancers 8) Past history of irradiation to the target region 9) Other medical or psychological unsuitable reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method two year survival rate
- Secondary Outcome Measures
Name Time Method local control rate, progression free survival, complication rate